{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T00:30:13Z","timestamp":1719448213577},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,25]]},"DOI":"10.7759\/cureus.63168","type":"journal-article","created":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T05:25:40Z","timestamp":1719379540000},"source":"Crossref","is-referenced-by-count":0,"title":["A Case of Fournier's Gangrene Following the Initiation of Dapagliflozin"],"prefix":"10.7759","author":[{"given":"Natalie","family":"Shaykh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Avni","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melville C","family":"O'Brien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oshin","family":"Rai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanshika","family":"Tripathi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vishal","family":"Jaikaransingh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-1884","article-title":"SGLT2 inhibitors may predispose to ketoacidosis","volume":"100","author":"Taylor SI","year":"2015","unstructured":"Taylor SI, Blau JE, Rother KI. SGLT2 inhibitors may predispose to ketoacidosis. J Clin Endocrinol Metab. 2015, 100:2849-52. 10.1210\/jc.2015-1884","journal-title":"J Clin Endocrinol Metab"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.12659\/AJCR.921536","article-title":"Fournier's gangrene and diabetic ketoacidosis associated with sodium glucose co-transporter 2 (SGLT2) inhibitors: life-threatening complications","volume":"21","author":"Kasbawala K","year":"2020","unstructured":"Kasbawala K, Stamatiades GA, Majumdar SK. Fournier's gangrene and diabetic ketoacidosis associated with sodium glucose co-transporter 2 (SGLT2) inhibitors: life-threatening complications. Am J Case Rep. 2020, 21:e921536. 10.12659\/AJCR.921536","journal-title":"Am J Case Rep"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.7326\/M19-0085","article-title":"Fournier gangrene associated with sodium-glucose cotransporter-2 inhibitors: a review of spontaneous postmarketing cases","volume":"170","author":"Bersoff-Matcha SJ","year":"2019","unstructured":"Bersoff-Matcha SJ, Chamberlain C, Cao C, Kortepeter C, Chong WH. Fournier gangrene associated with sodium-glucose cotransporter-2 inhibitors: a review of spontaneous postmarketing cases. Ann Intern Med. 2019, 170:764-9. 10.7326\/M19-0085","journal-title":"Ann Intern Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s13300-020-00771-8","article-title":"SGLT2 inhibitors and the risk of hospitalization for Fournier\u2019s gangrene: a nested case-control study","volume":"11","author":"Wang T","year":"2020","unstructured":"Wang T, Patel SM, Hickman A, Liu X, Jones PL, Gantz I, Koro CE. SGLT2 inhibitors and the risk of hospitalization for Fournier\u2019s gangrene: a nested case-control study. Diabetes Ther. 2020, 11:711-23. 10.1007\/s13300-020-00771-8","journal-title":"Diabetes Ther"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2147\/OAEM.S238699","article-title":"Fournier gangrene in the emergency department: Diagnostic dilemmas, treatments and current perspectives","volume":"12","author":"Auerbach J","year":"2020","unstructured":"Auerbach J, Bornstein K, Ramzy M, Cabrera J, Montrief T, Long B. Fournier gangrene in the emergency department: Diagnostic dilemmas, treatments and current perspectives. Open Access Emerg Med. 2020, 12:353-64. 10.2147\/OAEM.S238699","journal-title":"Open Access Emerg Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2012.12.041","article-title":"Causative pathogens, antibiotic sensitivity, resistance patterns, and severity in a contemporary series of Fournier's gangrene","volume":"81","author":"Bjurlin MA","year":"2013","unstructured":"Bjurlin MA, O'Grady T, Kim DY, Divakaruni N, Drago A, Blumetti J, Hollowell CM. Causative pathogens, antibiotic sensitivity, resistance patterns, and severity in a contemporary series of Fournier's gangrene. Urology. 2013, 81:752-8. 10.1016\/j.urology.2012.12.041","journal-title":"Urology"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.29264","article-title":"rare but life-threatening case of Fournier\u2019s gangrene caused by sodium-glucose cotransporter-2 (SGLT2) inhibitor, empagliflozin","volume":"14","author":"Jahir T","year":"2022","unstructured":"Jahir T, Hossain S, Bagum M, Saidi A, Risal R, Schmidt M.  rare but life-threatening case of Fournier\u2019s gangrene caused by sodium-glucose cotransporter-2 (SGLT2) inhibitor, empagliflozin. Cureus. 2022, 14:e29264. 10.7759\/cureus.29264","journal-title":"Cureus"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2020-237784","article-title":"Fournier's gangrene with dapagliflozin in a rural hospital: a case report","volume":"14","author":"Elbeddini A","year":"2021","unstructured":"Elbeddini A, Tayefehchamani Y, Davey M, et al.. Fournier's gangrene with dapagliflozin in a rural hospital: a case report. BMJ Case Rep. 2021, 14:237784. 10.1136\/bcr-2020-237784","journal-title":"BMJ Case Rep"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.4081\/aiua.2016.3.157","article-title":"Fournier's gangrene. A clinical review","volume":"88","author":"Singh A","year":"2016","unstructured":"Singh A, Ahmed K, Aydin A, Khan MS, Dasgupta P. Fournier's gangrene. A clinical review. Arch Ital Urol Androl. 2016, 88:157-64. 10.4081\/aiua.2016.3.157","journal-title":"Arch Ital Urol Androl"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/MJT.0000000000001101","article-title":"Empagliflozin-associated Fournier gangrene","volume":"28","author":"Ubaid A","year":"2019","unstructured":"Ubaid A, Naeem A, Waheed F. Empagliflozin-associated Fournier gangrene. Am J Ther. 2019, 28:e495-7. 10.1097\/MJT.0000000000001101","journal-title":"Am J Ther"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/dme.13508","article-title":"Fournier's gangrene in a man on empagliflozin for treatment of type\u00a02 diabetes","volume":"34","author":"Kumar S","year":"2017","unstructured":"Kumar S, Costello AJ, Colman PG. Fournier's gangrene in a man on empagliflozin for treatment of type\u00a02 diabetes. Diabet Med. 2017, 34:1646-8. 10.1111\/dme.13508","journal-title":"Diabet Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3393\/ac.2020.06.22","article-title":"Fournier gangrene in a patient with type 2 diabetes mellitus treated with dapagliflozin: a case report","volume":"37","author":"Moon JY","year":"2021","unstructured":"Moon JY, Lee MR, Kim JH, Ha GW. Fournier gangrene in a patient with type 2 diabetes mellitus treated with dapagliflozin: a case report. Ann Coloproctol. 2021, 37:S48-50. 10.3393\/ac.2020.06.22","journal-title":"Ann Coloproctol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/261206-a-case-of-fourniers-gangrene-following-the-initiation-of-dapagliflozin","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T05:25:44Z","timestamp":1719379544000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/261206-a-case-of-fourniers-gangrene-following-the-initiation-of-dapagliflozin"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,25]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.63168","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6,25]]}}}